Oncostatin M, a novel profibrogenic mediator, is involved in the progression non-alcoholic fatty liver disease and stimulates migration of myofibroblasts. (February 2020) - Foglia, B.; Novo, E.; Sutti, S.; Cannito, S.; Protopapa, F.; Bocca, C.; Maggiora, M.; Rosso, C.; Bugianesi, E.; Albano, E.; Parola, M.